Author: Daniel snow

McKinsey & Company is reshaping its graduate hiring strategy, placing greater emphasis on artificial intelligence literacy while broadening recruitment beyond traditional business and engineering programs. The shift reflects growing demand from clients seeking guidance on AI adoption, automation, and digital transformation. Rather than focusing solely on technical specialists, McKinsey is increasingly targeting candidates from liberal arts and interdisciplinary backgrounds who can combine analytical thinking with strong communication skills. Firm leaders say AI tools are becoming foundational across consulting engagements, from data analysis to scenario modeling. As a result, new hires are expected to be comfortable working alongside AI systems, even…

Read More

Citigroup Chief Executive Jane Fraser has warned employees that further job cuts may be ahead as the bank accelerates a sweeping restructuring aimed at improving profitability and simplifying its global operations. In a blunt internal memo, Fraser emphasized that performance expectations are rising across the organization, signaling a shift toward a leaner and more disciplined operating model. The message follows a series of divestitures and organizational changes intended to refocus Citigroup on its core businesses. Fraser, who took the helm in 2021, has been under pressure to close the performance gap with rivals such as JPMorgan Chase and Bank of…

Read More

Peter Thiel has emerged as a major financial backer of efforts to block a proposed billionaire wealth tax in California, marking one of his most significant political interventions in recent years and adding momentum to an increasingly contentious policy debate. The proposed tax, which would apply annually to individuals with net worth exceeding a multibillion-dollar threshold, is designed to address income inequality and generate long-term revenue for public services. Supporters argue that California’s concentration of extreme wealth—particularly in technology and finance—makes the state uniquely positioned to test such a measure. Critics, however, warn that the policy could drive capital and…

Read More

Amgen CEO Bob Bradway told CNBC’s Jim Cramer he thinks his company’s obesity drug can help patients manage weight loss long term, which he indicated is a challenge.”We think we can address one of the reasons that the field is struggling a little bit, which is the patient persistence issue,” Bradway said. Amgen revealed Monday that a trial of its experimental GLP-1 drug, MariTide, showed that patients were able to maintain weight loss for two years when given a monthly injection. Right now, most widely-used weight loss injections are taken weekly. Bradway told Cramer that the pharmaceutical giant expects the…

Read More